AllPennyStocks.com California-Based Biotech Trading over +200% Premarket Following ...

California-Based Biotech Trading over +200% Premarket Following Acquisition Announcement

California-Based Biotech Trading over +200% Premarket Following Acquisition Announcement By: Tomas Ronolski - AllPennyStocks.com News

Tuesday, November 26, 2024

A California-based biotech company is already stealing the show so far during Tuesday’s premarket hours after it was announced that the company will be acquired by Roche in a $1.5 billion deal, with stockholders receiving up to $13 per share in cash.

Seeing that Poseida Therapeutics Inc. (Nasdaq:PSTX) closed at just $2.86/share yesterday, it’s no wonder that traders are rushing to get their hands on the small cap. At the time of writing, traders are currently bid at $9.36/share (+227.27% implied open for sellers). It should be an exciting session for this healthcare stock!

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet delivery technology. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.


Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Continued Crypto Adoption Pushes Shares Of This Crypto Trading Platform Higher
California-Based Biotech Trading over +200% Premarket Following Acquisition Announcement
Shares Take Off Following Binding Offtake Agreement
Most Popular


Back to Top